Get answers,
get FHACT.
Webinar series.

LEARN MORE >

A new aid in cervical cancer screening.

LEARN MORE >

FHACT is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT, the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

22 Jul 14

Cancer Genetics, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference (read more...)

- RUTHERFORD, N.J., July 22, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based (read more...)
21 Jul 14

Cancer Genetics Announces Acquisition of Gentris Corporation, a Leading Global Pharmacogenomics Company, and Increases Contract Backlog to Over $18 Million (read more...)

- Acquisition Adds Contracts With Five of the Top Biopharma Companies Globally Increases Overall Biopharma Contract Backlog to Over $18 (read more...)

Events

06 Dec 14

ASH Annual Meeting

14 Nov 14

Iowa Oncology Society Fall Membership Conference

13 Nov 14

AMP Annual Meeting

Clinicians
Patients